Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.
์ข
๋ชฉ ์ฝ๋ ADVB
ํ์ฌ ์ด๋ฆAdvanced Biomed Inc
์์ฅ์ผMar 06, 2025
CEO- -
์ง์ ์31
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃMar 06
์ฃผ์401 Ryland St
๋์RENO
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ89502
์ ํ1862120510823
์น์ฌ์ดํธhttp://www.advanbiomed.com/
์ข
๋ชฉ ์ฝ๋ ADVB
์์ฅ์ผMar 06, 2025
CEO- -
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์